Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
DME treatment
VICTUS receives CE approval
Intensive fundus screenings
OSAHS linked to NTG
 

Survey

Do you currently use intensive fundus screening on children with retinoblastoma?

Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.

Click here to contact Neil Hanley, sales manager.

December 21, 2011
Tissue-sparing laser therapy successfully treats DME
Iridex Corporation have announced the results of a 10 year study confirming the safety and efficacy of using MicroPulse laser therapy for the treatment of diabetic macular oedema (DME). More...
CE mark of approval given to femtosecond laser platform
The VICTUS femtosecond laser platform has received the CE mark of approval. More...
Intensive fundus screenings reduces need for enucleation
Intensive fundus screening in retinoblastoma patients decreases the need for enucleation and external beam radiation (EBRT). More...
Obstructive sleep apnoea/hypopnoea syndrome linked to NTG
Moderate and severe obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is strongly linked to normal tension glaucoma (NTG). More...
Survey
At Ophthalmology Times Europe we would like to know more about the choices our readers make on behalf of their Dry Eye patients.
By clicking here and completing our short survey you could have a chance to win one of three iPad2’s!

Closing date for completed surveys is 9th December 2011 . Click here...
Profile
Alcon Supplement
A diagnostic & treatment strategy for dry eye associated With Meibomian Gland Dysfunction (MGD).
Read more:

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH. United Kingdom